290 related articles for article (PubMed ID: 35635171)
1. Impact of Primary and Secondary Bile Acids on
Łukawska A; Mulak A
Pol J Microbiol; 2022 Mar; 71(1):11-18. PubMed ID: 35635171
[TBL] [Abstract][Full Text] [Related]
2. Gut associated metabolites and their roles in
Aguirre AM; Sorg JA
Gut Microbes; 2022; 14(1):2094672. PubMed ID: 35793402
[TBL] [Abstract][Full Text] [Related]
3. Bile salt hydrolases shape the bile acid landscape and restrict Clostridioides difficile growth in the murine gut.
Foley MH; Walker ME; Stewart AK; O'Flaherty S; Gentry EC; Patel S; Beaty VV; Allen G; Pan M; Simpson JB; Perkins C; Vanhoy ME; Dougherty MK; McGill SK; Gulati AS; Dorrestein PC; Baker ES; Redinbo MR; Barrangou R; Theriot CM
Nat Microbiol; 2023 Apr; 8(4):611-628. PubMed ID: 36914755
[TBL] [Abstract][Full Text] [Related]
4. Shengjiang Xiexin decoction mitigates murine Clostridium difficile infection through modulation of the gut microbiota and bile acid metabolism.
Yu XH; Lv Z; Zhang CE; Gao Y; Li H; Ma XJ; Ma ZJ; Su JR; Huang LQ
J Ethnopharmacol; 2024 Feb; 320():117384. PubMed ID: 37925000
[TBL] [Abstract][Full Text] [Related]
5. Ursodeoxycholic Acid (UDCA) Mitigates the Host Inflammatory Response during Clostridioides difficile Infection by Altering Gut Bile Acids.
Winston JA; Rivera AJ; Cai J; Thanissery R; Montgomery SA; Patterson AD; Theriot CM
Infect Immun; 2020 May; 88(6):. PubMed ID: 32205405
[No Abstract] [Full Text] [Related]
6. Clostridioides difficile infection induces a rapid influx of bile acids into the gut during colonization of the host.
Wexler AG; Guiberson ER; Beavers WN; Shupe JA; Washington MK; Lacy DB; Caprioli RM; Spraggins JM; Skaar EP
Cell Rep; 2021 Sep; 36(10):109683. PubMed ID: 34496241
[TBL] [Abstract][Full Text] [Related]
7. Changes in microbiota composition, bile and fatty acid metabolism, in successful faecal microbiota transplantation for Clostridioides difficile infection.
Brown JR; Flemer B; Joyce SA; Zulquernain A; Sheehan D; Shanahan F; O'Toole PW
BMC Gastroenterol; 2018 Aug; 18(1):131. PubMed ID: 30153805
[TBL] [Abstract][Full Text] [Related]
8. A strain of Bacteroides thetaiotaomicron attenuates colonization of Clostridioides difficile and affects intestinal microbiota and bile acids profile in a mouse model.
Li X; Kang Y; Huang Y; Xiao Y; Song L; Lu S; Ren Z
Biomed Pharmacother; 2021 May; 137():111290. PubMed ID: 33508620
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of CamSA, a potential prophylactic compound against Clostridioides difficile infections.
Yip C; Okada NC; Howerton A; Amei A; Abel-Santos E
Biochem Pharmacol; 2021 Jan; 183():114314. PubMed ID: 33152344
[TBL] [Abstract][Full Text] [Related]
10. The microbial-derived bile acid lithocholate and its epimers inhibit
Kisthardt SC; Thanissery R; Pike CM; Foley MH; Theriot CM
J Bacteriol; 2023 Sep; 205(9):e0018023. PubMed ID: 37695856
[No Abstract] [Full Text] [Related]
11. Review and Commentary on the Importance of Bile Acids in the Life Cycle of Clostridioides difficile in Children and Adults.
Faden H
J Pediatric Infect Dis Soc; 2021 May; 10(5):659-664. PubMed ID: 33626138
[TBL] [Abstract][Full Text] [Related]
12. Bile salt metabolism is not the only factor contributing to
Jukes CA; Ijaz UZ; Buckley A; Spencer J; Irvine J; Candlish D; Li JV; Marchesi JR; Douce G
Gut Microbes; 2020 May; 11(3):481-496. PubMed ID: 31793403
[TBL] [Abstract][Full Text] [Related]
13. Bile Acids and Microbiota: Multifaceted and Versatile Regulators of the Liver-Gut Axis.
Grüner N; Mattner J
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573273
[TBL] [Abstract][Full Text] [Related]
14.
Saenz C; Fang Q; Gnanasekaran T; Trammell SAJ; Buijink JA; Pisano P; Wierer M; Moens F; Lengger B; Brejnrod A; Arumugam M
Microbiol Spectr; 2023 Sep; 11(5):e0393322. PubMed ID: 37750706
[No Abstract] [Full Text] [Related]
15. Mechanisms of Colonization Resistance Against Clostridioides difficile.
Pike CM; Theriot CM
J Infect Dis; 2021 Jun; 223(12 Suppl 2):S194-S200. PubMed ID: 33326565
[TBL] [Abstract][Full Text] [Related]
16. Functional Intestinal Bile Acid 7α-Dehydroxylation by
Studer N; Desharnais L; Beutler M; Brugiroux S; Terrazos MA; Menin L; Schürch CM; McCoy KD; Kuehne SA; Minton NP; Stecher B; Bernier-Latmani R; Hapfelmeier S
Front Cell Infect Microbiol; 2016; 6():191. PubMed ID: 28066726
[TBL] [Abstract][Full Text] [Related]
17. Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent
Mullish BH; McDonald JAK; Pechlivanis A; Allegretti JR; Kao D; Barker GF; Kapila D; Petrof EO; Joyce SA; Gahan CGM; Glegola-Madejska I; Williams HRT; Holmes E; Clarke TB; Thursz MR; Marchesi JR
Gut; 2019 Oct; 68(10):1791-1800. PubMed ID: 30816855
[TBL] [Abstract][Full Text] [Related]
18. Diversification of host bile acids by members of the gut microbiota.
Winston JA; Theriot CM
Gut Microbes; 2020; 11(2):158-171. PubMed ID: 31595814
[TBL] [Abstract][Full Text] [Related]
19. Obeticholic acid ameliorates severity of Clostridioides difficile infection in high fat diet-induced obese mice.
Jose S; Mukherjee A; Horrigan O; Setchell KDR; Zhang W; Moreno-Fernandez ME; Andersen H; Sharma D; Haslam DB; Divanovic S; Madan R
Mucosal Immunol; 2021 Mar; 14(2):500-510. PubMed ID: 32811993
[TBL] [Abstract][Full Text] [Related]
20.
Cheng JKJ; Unnikrishnan M
Microbiology (Reading); 2023 Feb; 169(2):. PubMed ID: 36848200
[No Abstract] [Full Text] [Related]
[Next] [New Search]